
Sign up to save your podcasts
Or


ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS. Related Content:
By JAMA Network4.6
162162 ratings
ARDS, which is characterized by hypoxemic respiratory failure and inflammatory injury to the lungs, has a mortality rate of 30% to 40%. Balasubramanian Venkatesh, MD, of the George Institute for Global Health joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the effects of inhaled sedation with sevoflurane for patients with moderate to severe ARDS. Related Content:

6,699 Listeners

43,540 Listeners

38,764 Listeners

21,636 Listeners

138 Listeners

322 Listeners

702 Listeners

498 Listeners

764 Listeners

881 Listeners

3,337 Listeners

21 Listeners

13 Listeners

16 Listeners

7 Listeners

18 Listeners

30 Listeners

194 Listeners

88 Listeners

367 Listeners

6,362 Listeners

19 Listeners